Fevertree Drinks (GB:FEVR)
LSE:FEVR
Top Page
Fevertree Drinks
(LSE:FEVR)
Select Model
Select Model
Rating:57Neutral
Price Target:
817.00 p
▲(5.15% Upside)
Action:DowngradedDate:03/26/26
Overall score is driven by a strong, low-leverage balance sheet but offset by weaker recent operating trends and volatile cash generation. Technicals are notably weak (below major moving averages with negative MACD), and valuation is stretched given the high P/E despite a moderate dividend yield.
Positive Factors
Low Leverage / Strong Balance Sheet
Extremely low debt and substantial equity provide durable financial flexibility: the company can fund marketing, product investment, working-capital swings or opportunistic buybacks/M&A without high interest burden. This reduces solvency risk through economic cycles.
Negative Factors
Recent Revenue Contraction
A recent top-line decline signals weakening demand or channel pressures; if prolonged this erodes scale advantages, reduces pricing leverage, and constrains reinvestment. Sustained revenue contraction would impair long-term growth and margin recovery prospects.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage / Strong Balance Sheet
Extremely low debt and substantial equity provide durable financial flexibility: the company can fund marketing, product investment, working-capital swings or opportunistic buybacks/M&A without high interest burden. This reduces solvency risk through economic cycles.
Read all positive factors
Fevertree Drinks (FEVR) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£896.49M
Dividend Yield2.11%
Average Volume (3M)455.71K
Price to Earnings (P/E)43.6
Beta (1Y)1.25
Revenue Growth-6.03%
EPS Growth13.11%
CountryUK
Employees380
SectorConsumer Defensive
Sector Strength42
IndustryBeverages - Non-Alcoholic
Share Statistics
EPS (TTM)0.12
Shares Outstanding115,378,075
10 Day Avg. Volume337,958
30 Day Avg. Volume455,715
Financial Highlights & Ratios
PEG Ratio-4.58
Price to Book (P/B)4.42
Price to Sales (P/S)3.03
P/FCF Ratio32.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£981.93Price Target Upside26.38% Upside
Rating ConsensusHold
Number of Analyst Covering9
EPS Forecast (FY)0.28
Revenue Forecast (FY)£395.20M
Fevertree Drinks Business Overview & Revenue Model
Company Description
Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company's products include Indian tonic water, Mediterranean tonic water, e...
How the Company Makes Money
Fevertree primarily makes money by selling Fever-Tree branded mixers to trade customers, recognizing revenue from the sale of finished bottled/canned products. Its core revenue stream is wholesale distribution of premium mixers (notably tonic wate...
Fevertree Drinks Earnings Call Summary
Earnings Call Date:Sep 12, 2024
(Q2-2024)
| % Change Since: |
Next Earnings Date:Sep 15, 2026
Earnings Call Sentiment Positive
The earnings call highlighted strong performance in the U.S. market, significant EBITDA and gross margin improvements, and robust growth in non-tonic products. However, challenges remain in the UK and European markets, with revenue declines and on-trade channel difficulties noted. Despite these challenges, the company is optimistic about future growth opportunities.Positive Updates
Significant EBITDA Growth
Fevertree delivered almost 80% EBITDA growth, indicating strong margin recovery.
Negative Updates
Decline in UK Revenue
UK revenue declined by 6% year-on-year, primarily due to the challenging on-trade backdrop and continued weakness of the gin category.
Read all updates
Q2-2024 Updates
Positive
Negative
Significant EBITDA Growth
Fevertree delivered almost 80% EBITDA growth, indicating strong margin recovery.
Read all positive updates
Company Guidance
During the Fevertree Q2 2024 earnings call, the company provided guidance indicating strong financial performance despite challenging market conditions. The executives highlighted an impressive 80% growth in EBITDA and a 520 basis point improvement in gross margin during the first half, with a commitment to achieve 600 basis points for the full year. Revenue growth was reported at 2% on a constant currency basis, with the U.S. market showing double-digit growth and outpacing the total mixer category by 10%. In the U.K., Fevertree maintained its position as the number one brand by value, although it faced challenges in the on-trade sector due to poor weather. The European market saw a 10% decline at constant currency, impacted by weather and order phasing, but underlying brand revenue increased by 1% year-on-year. The Rest of the World region experienced a 56% revenue increase, driven by strong performance in Australia and Canada. Looking ahead, Fevertree anticipates revenue growth acceleration and continued margin recovery, with expectations to deliver a further 200 basis point gross margin improvement in 2025, despite ongoing macroeconomic challenges.Fevertree Drinks Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
88
Very Positive
Cash Flow
55
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 325.00M | 368.50M | 364.40M | 344.30M | 311.10M |
| Gross Profit | 107.30M | 138.40M | 109.00M | 118.80M | 130.90M |
| EBITDA | 36.90M | 45.70M | 30.80M | 37.20M | 60.60M |
| Net Income | 22.60M | 24.40M | 15.40M | 24.90M | 44.60M |
Balance Sheet | |||||
| Total Assets | 287.00M | 321.90M | 313.70M | 311.60M | 336.10M |
| Cash, Cash Equivalents and Short-Term Investments | 91.10M | 96.00M | 59.90M | 95.30M | 166.20M |
| Total Debt | 3.80M | 12.10M | 15.20M | 16.90M | 2.90M |
| Total Liabilities | 63.90M | 75.20M | 75.90M | 72.40M | 54.50M |
| Stockholders Equity | 223.10M | 246.70M | 237.80M | 239.20M | 281.60M |
Cash Flow | |||||
| Free Cash Flow | 30.30M | 56.10M | -13.40M | 1.40M | 42.20M |
| Operating Cash Flow | 33.60M | 70.20M | -3.80M | 8.50M | 46.80M |
| Investing Cash Flow | 13.10M | -10.80M | -9.60M | -10.00M | -4.30M |
| Financing Cash Flow | -51.20M | -23.60M | -23.10M | -70.70M | -19.30M |
Fevertree Drinks Technical Analysis
Negative
777.00
Price Trends
883.24
Negative
850.50
Negative
864.97
Negative
Market Momentum
-34.14
Positive
33.97
Neutral
54.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:FEVR, the sentiment is Negative. The current price of 777 is below the 20-day moving average (MA) of 830.90, below the 50-day MA of 883.24, and below the 200-day MA of 864.97, indicating a bearish trend. The MACD of -34.14 indicates Positive momentum. The RSI at 33.97 is Neutral, neither overbought nor oversold. The STOCH value of 54.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:FEVR.
Fevertree Drinks Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £15.42B | 17.33 | 28.56% | 1.96% | 6.00% | 42.42% | |
72 Outperform | £332.71M | 16.26 | 23.59% | 3.39% | 3.04% | -6.67% | |
70 Outperform | £688.62M | 7.17 | 15.23% | 2.74% | 3.97% | 34.09% | |
65 Neutral | £405.90M | 9.36 | 3.72% | 4.05% | -2.22% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | £896.49M | 43.61 | 9.32% | 2.11% | -6.03% | 13.11% | |
54 Neutral | £56.60M | -32.71 | -6.01% | ― | ― | ― |
* Consumer Defensive Sector Average
GB:FEVR
Fevertree Drinks
777.00
-18.55
-2.33%
GB:BAG
AG Barr
619.00
20.10
3.36%
GB:CCH
Coca Cola HBC
4,242.00
815.19
23.79%
GB:NICL
Nichols
910.00
-338.90
-27.14%
GB:CCR
C&C Group Plc
110.20
-14.67
-11.75%
GB:CDGP
Chapel Down Group plc
33.00
-5.00
-13.16%
Fevertree Drinks Corporate Events
Business Operations and StrategyStock BuybackFinancial Disclosures
Fevertree grows revenue and diversifies range as U.S. transition hits margins
Neutral
Mar 24, 2026
Fevertree Drinks reported modest 2025 revenue growth, with Fever-Tree brand sales up 4% at constant currency and accelerating in the second half, even as adjusted EBITDA fell 16% due to the new U.S. partnership model, transition costs and increase...
Business Operations and StrategyStock Buyback
Fever-Tree Cancels Shares After Modest Buyback on London Market
Positive
Mar 23, 2026
Fever-Tree said it repurchased 15,405 of its own ordinary shares on 20 March 2026 on the London Stock Exchange, paying between 750 pence and 782 pence per share, at a volume‑weighted average price of 765.9740 pence. The buyback, executed via...
Stock BuybackRegulatory Filings and Compliance
Fevertree Drinks Buys Back and Cancels 16,000 Shares
Positive
Mar 20, 2026
Fevertree Drinks plc has repurchased 16,000 of its own ordinary shares on 19 March 2026 via broker Investec Bank at prices ranging between 773p and 803p, with a volume-weighted average price of about 784.9p. The company plans to cancel these share...
Business Operations and StrategyStock Buyback
Fever-Tree Cancels 15,640 Shares After Latest Buyback Tranche
Positive
Mar 19, 2026
Fevertree Drinks PLC has repurchased 15,640 of its own ordinary shares on 18 March 2026 under the shareholder authority granted at its 2025 annual meeting, paying between 805p and 830p per share with a volume-weighted average price of 815.2389p. T...
Business Operations and StrategyStock Buyback
Fevertree Cancels Newly Repurchased Shares in Ongoing Buyback Programme
Positive
Mar 18, 2026
Fevertree Drinks has repurchased 15,052 of its own ordinary shares on 17 March 2026 under authority granted at its 2025 annual meeting, paying between 822p and 833p per share at a volume-weighted average price of 826.6010p. The company plans to ca...
Business Operations and StrategyStock Buyback
Fevertree Drinks Buys Back and Cancels 15,129 Shares
Positive
Mar 17, 2026
Fevertree Drinks has repurchased 15,129 of its own ordinary shares on 16 March 2026 via broker Investec Bank at prices between 829p and 842p, with a volume-weighted average price of 835.5436p. The company intends to cancel these shares, a move tha...
Business Operations and StrategyStock Buyback
Fevertree Cancels 16,000 Shares After Targeted Buyback
Positive
Mar 16, 2026
Fevertree Drinks plc has repurchased 16,000 of its own ordinary shares on 13 March 2026 under the authority granted at its 2025 annual general meeting, paying a volume-weighted average price of about 831.9 pence, within a trading range of 824 to 8...
Business Operations and StrategyStock Buyback
Fever-Tree buys back and cancels 16,000 shares in latest capital move
Positive
Mar 13, 2026
Fevertree Drinks has repurchased 16,000 of its ordinary shares on 12 March 2026 via its broker Investec Bank at prices ranging between 819p and 835p, with a volume-weighted average price of about 828p. The company plans to cancel these shares, a m...
Business Operations and StrategyStock Buyback
Fever-Tree Cancels Shares After Targeted Buyback on London Market
Positive
Mar 12, 2026
Fevertree Drinks plc has repurchased 15,739 of its own ordinary shares on 11 March 2026 via broker Investec Bank at prices between 835p and 845p, with a volume-weighted average price of about 840.9p. The company plans to cancel these shares, a mov...
Stock Buyback
Fevertree Cancels Newly Repurchased Shares in Ongoing Buyback
Positive
Mar 11, 2026
Fevertree Drinks has continued its share buyback programme, repurchasing 15,917 ordinary shares on 10 March 2026 via broker Investec Bank at prices between 840p and 860p, with a volume‑weighted average price of about 849.4p. The company plan...
Business Operations and StrategyStock Buyback
Fevertree cancels 15,565 shares after latest buyback on London market
Positive
Mar 10, 2026
Fevertree Drinks has repurchased 15,565 of its ordinary shares on 9 March 2026 through broker Investec Bank, at prices ranging between 839p and 866p and a volume-weighted average price of about 850.6p. The company plans to cancel these shares, mod...
Business Operations and StrategyStock Buyback
Fever-Tree Cancels Shares After Targeted Buyback on London Market
Positive
Mar 10, 2026
Fever-Tree Drinks has continued its capital management programme, repurchasing 15,565 ordinary shares on 9 March 2026 under an existing shareholder authority, at prices between 839p and 866p and a volume-weighted average of about 850.57p. The comp...
Business Operations and StrategyStock Buyback
Fevertree Cancels Shares After Targeted Buyback on London Market
Positive
Mar 9, 2026
Fevertree Drinks has executed a small share buyback on 6 March 2026 under authority granted at its 2025 AGM, repurchasing 15,937 ordinary shares on the London Stock Exchange at prices between 881p and 900p, with a volume-weighted average price of ...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Fever-Tree Buys Back and Cancels 15,671 Shares in Capital Management Move
Positive
Mar 6, 2026
Fevertree Drinks has repurchased 15,671 of its own ordinary shares on 5 March 2026 under shareholder authority granted at the 2025 AGM, paying prices between 892p and 909p and a volume-weighted average price of about 900.94p. The company plans to ...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Fevertree Cancels 15,871 Shares After Latest Buyback on LSE
Positive
Mar 5, 2026
Fevertree Drinks plc has repurchased 15,871 of its own ordinary shares on 4 March 2026 through broker Investec Bank at prices between 895p and 920p, with a volume-weighted average price of 906.5795p. The company plans to cancel these shares, sligh...
Stock Buyback
Fevertree Drinks Cancels 15,871 Shares After Latest Buyback
Positive
Mar 5, 2026
Fevertree Drinks plc has repurchased 15,871 of its own ordinary shares on 4 March 2026 via broker Investec Bank, at prices ranging between 895p and 920p and a volume-weighted average price of 906.5795p. The company plans to cancel these shares, ma...
Business Operations and StrategyStock Buyback
Fevertree Cancels 16,000 Shares After Latest Buyback
Positive
Mar 4, 2026
Fevertree Drinks plc has repurchased 16,000 of its own ordinary shares on 3 March 2026 via its broker Investec Bank, at prices ranging between 900p and 930p and a volume-weighted average price of 910.5601p. The company plans to cancel these shares...
Regulatory Filings and Compliance
Fever-Tree Confirms Total Voting Rights at 115.6 Million Shares
Neutral
Mar 3, 2026
Fever-Tree Drinks has confirmed that its total issued share capital stands at 115,598,003 ordinary shares, each carrying one voting right and with no shares held in treasury. This disclosure sets the official total voting rights at 115,598,003, pr...
Stock Buyback
Fever-Tree Cancels 15,576 Shares After Targeted Buyback on LSE
Positive
Mar 3, 2026
Fevertree Drinks has repurchased 15,576 of its own ordinary shares on 2 March 2026 through its broker Investec Bank at prices ranging between 936p and 951p, with a volume‑weighted average price of 943.79p. The company plans to cancel the sha...
Stock Buyback
Fevertree Cancels 15,431 Shares After Latest Buyback
Positive
Mar 2, 2026
Fevertree Drinks has repurchased 15,431 ordinary shares on 27 February 2026 under the authority granted at its 2025 AGM, paying prices between 943p and 967p and a volume-weighted average price of 953.0433p via its broker Investec Bank on the Londo...
Business Operations and StrategyStock Buyback
Fevertree Cancels 16,000 Shares After Latest Buyback Tranche
Positive
Feb 27, 2026
Fevertree Drinks has repurchased 16,000 of its own ordinary shares on 26 February 2026 under the buyback authority granted at its 2025 annual general meeting, paying a volume-weighted average price of about 952.5 pence and a range between 941 and ...
Business Operations and StrategyStock Buyback
Fevertree Drinks Cancels 15,981 Shares After Fresh Buyback on London Market
Positive
Feb 26, 2026
Fevertree Drinks plc has repurchased 15,981 of its own ordinary shares on 25 February 2026 under the authority granted at its 2025 AGM, paying a volume-weighted average price of about 943.12 pence, with trades executed on the London Stock Exchange...
Business Operations and StrategyStock Buyback
Fevertree Cancels 16,000 Shares in Ongoing Buyback Programme
Positive
Feb 25, 2026
Fevertree Drinks has continued its share buyback programme, repurchasing 16,000 ordinary shares on 24 February 2026 via Investec Bank at prices between 949p and 968p, with a volume-weighted average of 956.08p. The company plans to cancel these sha...
Business Operations and StrategyStock Buyback
Fevertree Cancels Newly Repurchased Shares in Ongoing Buyback
Positive
Feb 24, 2026
Fevertree Drinks plc has repurchased 15,520 ordinary shares on 23 February 2026 under a shareholder-approved buyback programme, paying a volume-weighted average price of 950.8548 pence, with trades executed through its broker Investec Bank on the ...
Business Operations and StrategyStock Buyback
Fever-Tree Cancels 16,000 Shares After Fresh Buyback Tranche
Positive
Feb 23, 2026
Fevertree Drinks has repurchased 16,000 of its own ordinary shares on 20 February 2026 via its broker Investec Bank at prices ranging between 936p and 962p, with a volume-weighted average price of about 953.7p. The company plans to cancel these sh...
Stock Buyback
Fever-Tree Buys Back and Cancels 16,000 Shares on London Market
Positive
Feb 20, 2026
Fever-Tree has repurchased 16,000 of its own ordinary shares on 19 February 2026 via broker Investec Bank at prices between 934p and 945p, with a volume-weighted average price of about 939.26p. The company intends to cancel these shares, modestly ...
Business Operations and StrategyStock Buyback
Fevertree Cancels Newly Repurchased Shares in Capital-Management Move
Positive
Feb 19, 2026
Fevertree Drinks said it repurchased 15,899 ordinary shares on 18 February 2026 on the London Stock Exchange under the shareholder authority granted at its 2025 AGM, paying a volume-weighted average price of about 949.94 pence. The company plans t...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Fevertree Cancels 15,588 Shares After Latest Buyback on London Market
Positive
Feb 18, 2026
Fevertree Drinks plc has repurchased 15,588 of its own ordinary shares on 17 February 2026 under the shareholder authority granted at its 2025 AGM, paying a volume-weighted average price of 961.16 pence, within a daily range of 949 to 969 pence. T...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Fevertree Drinks Buys Back and Cancels 16,000 Shares in Capital Management Move
Positive
Feb 17, 2026
Fevertree Drinks has repurchased 16,000 of its own ordinary shares on 16 February 2026 via broker Investec Bank, paying a volume‑weighted average price of about 963.78 pence, within a range of 957 to 972 pence. The company plans to cancel th...
Business Operations and StrategyStock Buyback
Fevertree Drinks Buys Back and Cancels 15,340 Shares in Capital Management Move
Positive
Feb 16, 2026
Fevertree Drinks has repurchased 15,340 of its ordinary shares on 13 February 2026 under the shareholder authority granted at its 2025 annual general meeting, paying a volume-weighted average price of about 959.78 pence and ranging between 953 and...
Stock Buyback
Fevertree Cancels 15,950 Shares After Latest Buyback on LSE
Positive
Feb 13, 2026
Fevertree Drinks said it repurchased 15,950 of its own ordinary shares on 12 February 2026, under the authority granted at its 2025 annual meeting. The shares were bought on the London Stock Exchange through Investec at prices between 951p and 966...
Business Operations and StrategyStock Buyback
Fever-Tree Buys Back and Cancels 15,830 Shares Under AGM Mandate
Positive
Feb 12, 2026
Fever-Tree has repurchased 15,830 of its own ordinary shares on 11 February 2026 under a buyback authority granted at its 2025 AGM, paying a volume-weighted average price of 950.7010p and executing the trades on the London Stock Exchange. The comp...
Business Operations and StrategyStock Buyback
Fever-Tree Buys Back and Cancels 13,544 Shares in Capital Management Move
Positive
Feb 11, 2026
Fever-Tree has repurchased 13,544 of its own ordinary shares on 10 February 2026, under the authority granted at its 2025 AGM, at prices ranging from 915p to 938p and a volume-weighted average price of 926.46p. The company plans to cancel the boug...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Fever-Tree Cancels Newly Repurchased Shares in Ongoing Buyback Programme
Positive
Feb 10, 2026
Fever-Tree Drinks plc has repurchased 15,695 of its own ordinary shares on 9 February 2026 under a shareholder-authorised buyback programme, paying a volume-weighted average price of 922.0448 pence, with trades executed between 909 and 934 pence t...
Business Operations and StrategyStock Buyback
Fevertree Drinks Cancels Shares After Targeted Buyback
Positive
Feb 10, 2026
Fevertree Drinks has repurchased 15,695 of its own ordinary shares on 9 February 2026 under the shareholder authority granted at its 2025 annual meeting. The trades, carried out by Investec Bank on the London Stock Exchange at a volume-weighted av...
Business Operations and StrategyStock Buyback
Fever-Tree Cancels Shares After Latest Buyback on London Market
Positive
Feb 9, 2026
Fever-Tree has continued its share buyback activity, repurchasing 15,944 ordinary shares on 6 February 2026 under the authority granted at its 2025 annual meeting. The shares were acquired via Investec Bank on the London Stock Exchange at prices b...
Business Operations and StrategyStock Buyback
Fevertree Cancels 15,785 Shares After Latest Buyback on London Market
Positive
Feb 6, 2026
Fevertree Drinks plc has repurchased 15,785 of its own ordinary shares on 5 February 2026 via broker Investec Bank at prices ranging between 882p and 895p, with a volume-weighted average price of 888.12p on the London Stock Exchange. The company i...
Business Operations and StrategyStock Buyback
Fevertree Cancels 16,000 Shares After Latest Buyback Transaction
Positive
Feb 5, 2026
Fevertree Drinks plc has repurchased 16,000 of its own ordinary shares on 4 February 2026 under the authority granted at its 2025 AGM, paying a volume‑weighted average price of 881.79 pence, within a trading range of 866 to 890 pence per sha...
Business Operations and StrategyStock Buyback
Fevertree Drinks Buys Back and Cancels 14,286 Own Shares
Positive
Feb 4, 2026
Fevertree Drinks has repurchased 14,286 of its own ordinary shares on 3 February 2026 via its broker Investec Bank at prices between 875p and 898p, with a volume-weighted average price of 884.38p per share. The company plans to cancel the shares, ...
Business Operations and StrategyStock Buyback
Fevertree Buys Back and Cancels 15,000 Shares in Capital Management Move
Positive
Feb 3, 2026
Fevertree Drinks plc has repurchased 15,000 of its own ordinary shares on 2 February 2026 via broker Investec Bank on the London Stock Exchange, at prices ranging between 876p and 897p and a volume‑weighted average price of 888.6173p per sha...
Regulatory Filings and Compliance
Fever-Tree Confirms Total Voting Rights at 115.8 Million Shares
Neutral
Feb 2, 2026
Fever-Tree has confirmed that its total issued share capital stands at 115,811,855 ordinary shares of 0.25p each, with one voting right attached to every share and no shares held in treasury. The disclosure clarifies the company’s overall vo...
Business Operations and StrategyStock Buyback
Fever-Tree Launches £30m Share Buyback to Cut Share Capital
Positive
Feb 2, 2026
Fever-Tree Drinks plc has launched a share buyback programme of up to £30 million in ordinary shares, appointing Investec Bank plc to execute purchases on a non-discretionary basis between 2 February and 31 December 2026. The buyback is inten...
Business Operations and StrategyStock BuybackFinancial Disclosures
Fever-Tree Beats 2025 Expectations and Extends Buyback as US Partnership Gains Traction
Positive
Jan 29, 2026
Fever-Tree Drinks expects its 2025 adjusted revenue and adjusted EBITDA to come in marginally ahead of market expectations, supported by a 4% increase in full-year Fever-Tree brand revenue at constant currency and solid second-half momentum. Regio...
Regulatory Filings and Compliance
Fever-Tree Confirms Total Voting Rights at 115.8 Million Shares
Neutral
Jan 6, 2026
Fever-Tree has confirmed that its issued share capital comprises 115,810,846 ordinary shares, each carrying one vote, with no shares held in treasury. This disclosure sets the official total voting rights figure that shareholders must use when cal...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.